even if there was some sort of "Synergy Deal" alive, there weren't any Synergy sales in Q4, IMO, and in another three weeks we can safely say that there weren't any Synergy sales in Q1 2023 either.
Because if BIEL had any Synergy revenues -- any at all, even $30,000 -- Staelin would get a PR out, IMO. Staelin knows that pinksheet biotech lives, breathes, and dies by the PR, and he's got a significant amount of cash tied up in this company, and he must have lent them MORE money in Q4.
There is no point in hiding Synergy revenues. No point whatsoever. Even if the revenues are small, they could release a PR saying they got their first Synergy order without disclosing the $$$ amount.
If some of the Q3 Deferred Revenues got converted into sales in Q4, we might see $100,000 or even $150,000 in Q4. Woo hoo! that would be a 200% increase over the previous quarter's $48k, or in Kelly's bizarro world of accounting, a 300% increase over the previous quarter!
And yea unto thee, the Ask shall be Slapped as the BIEL Rocket Ship goes to the Moon and Beyond.
Wait, let me rephrase that: the BIEL Sales VP will go to the corner store for a Moon Pie.
News flash: I may have figured out the problem -- BIEL management has been eating these and keeps forgetting to release that PR: